Frailty, Hip Fractures and Inflammatory Biomarkers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorUniversity of Thessaly
About this trial
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Eligibility criteria
Qualifiers
age >65 years, ASA PS I-III, non- institutionalized, able to communicate patients
Disqualifiers
Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov